Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). - Wikidata - wikimedia - TriplyDB

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

http://www.wikidata.org/entity/Q44526972

about

Gender analysis of moxifloxacin clinical trials A focus on intra-abdominal infections.2013 WSES guidelines for management of intra-abdominal infections.Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Delafloxacin: design, development and potential place in therapy Update on the cardiac safety of moxifloxacin.Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.Severe autogenously fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion. Response to intra peritoneal moxifloxacin combined with dexamethasone.Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis.Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.

P2860

Q28538319-8FF0A346-1C23-4ABC-A761-F449A09E4F69 Q33763449-F3896148-76AD-481E-8AC0-B765E2935E4D Q34321150-5423B300-D26B-43A6-9987-F3F5DC865529 Q34330502-41688A75-C8DB-45C2-9A24-C5493FCC3F2C Q34541183-54C22BFA-9A17-4909-8BEC-7BC0E4924A9D Q34554381-4A59C0E4-AC8D-449A-AC2D-6848FFEC683B Q36345861-2CB53C68-B2FE-4424-93A1-57E0667C980A Q37612940-390D5612-CC5E-4AEB-9BCD-92512469D7AB Q37976854-C47FB8C1-8664-432A-B4F1-6947B2705B2B Q44778276-6960E7C6-87EF-4F3E-9D78-769CFA732524 Q45074770-0FCF3E75-F644-445F-BA56-A55F21F5A49B Q45330989-E3B9A4FA-85B5-4749-9347-60415FB73BCB Q46770277-93D16CF9-799E-436E-829D-91B009B62F8B

P2860

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).

http://www.wikidata.org/entity/Q44526972

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Moxifloxacin for the treatment ...... l infections (the AIDA Study).

@en

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections

@nl

type

label

Moxifloxacin for the treatment ...... l infections (the AIDA Study).

@en

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections

@nl

prefLabel

Moxifloxacin for the treatment ...... l infections (the AIDA Study).

@en

Moxifloxacin for the treatment of patients with complicated intra-abdominal infections

@nl

P1433

Q44526972-DC7D6FD6-91F4-44E0-AE5E-768FA3B305FE

P1476

Q44526972-65482773-5746-4872-93B4-9D24D7B241A9

P2093

Q44526972-47904438-815A-45BA-8509-E6D2B7FF3074

Q44526972-637AB9ED-67D0-4E42-9E6A-25B0148B7936

Q44526972-7BCF1D4B-099D-47CF-99FE-38243F56C6C9

Q44526972-9CD92897-7D33-4FD8-A9DE-563A13F72EE2

Q44526972-A19B769F-1467-4537-B1E4-9F57054B59F7

Q44526972-B8F72BEB-D1F1-4D64-B3B7-3BA0A5D6A681

P2860

Q44526972-055399E8-9FEB-45D5-99CD-8B4B88232B3C

Q44526972-1CD8ACC1-5C13-4CA9-B492-11A5DD47D223

Q44526972-25F360E4-16FD-4B03-A490-02D4BE5830FF

Q44526972-64E4D6D8-E161-4507-85D4-269C4809D557

Q44526972-83733C19-39F8-495A-B947-6EC4FC9FF567

Q44526972-B923713E-5E9D-44EE-9DE9-7C65B1771B5A

Q44526972-C7B41072-7C1A-4ABC-86ED-62CAA121C8F2

Q44526972-D4BEB34A-61EF-437B-B724-B9E71BEFE126

Q44526972-E0DDF129-B755-47BF-8EEB-070708CC978E

Q44526972-E1C49E25-8942-4AFA-A2D0-007C12DC7893

P304

Q44526972-151E1BF8-3201-4907-9479-DAD8751C3EAF

P31

Q44526972-3A7E335C-4D03-4567-82A1-6EBDA6F187D9

P356

Q44526972-E70F7456-DBA1-4A09-873C-B977797F12DD

P433

Q44526972-00E48DAD-9808-4EBD-B834-D0866DDD5252

P478

Q44526972-3DD8DDB7-1755-4CD5-9BEA-8EF2C6D831B2

P577

Q44526972-241EF18E-50F6-46B9-9D7B-466888CEAE1C

P698

Q44526972-8384242D-BDAE-4B4C-9F0E-52C97CD774C4

P356

JOC.2009.21.2.170

P1433

Journal of Chemotherapy

P1476

Moxifloxacin for the treatment ...... l infections (the AIDA Study).

@en

P2093

AIDA Study Group

http://www.w3.org/2001/XMLSchema#string

B Hampel

http://www.w3.org/2001/XMLSchema#string

E Muehlhofer

http://www.w3.org/2001/XMLSchema#string

G Weiss

http://www.w3.org/2001/XMLSchema#string

H Lippert

http://www.w3.org/2001/XMLSchema#string

P Reimnitz

http://www.w3.org/2001/XMLSchema#string

P2860

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

Future directions in the management of tertiary peritonitis.

Intensive care unit management of intra-abdominal infection.

Critical issues in the clinical management of complicated intra-abdominal infections.

Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.

Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.

Moxifloxacin penetration into human gastrointestinal tissues.

The microbiology of postoperative peritonitis.

P304

170-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/JOC.2009.21.2.170

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19423470

http://www.w3.org/2001/XMLSchema#string